Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.

Item
http://www.wikidata.org/entity/Q40520588
Patient Reported Outcome Measures (PROMs) in Inflammatory Bowel Disease: New Data.Dose de-escalation to adalimumab 40 mg every 3 weeks in patients with Crohn's disease - a nested case-control study.Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.Usefulness of fecal calprotectin for the early prediction of short-term outcomes of remission-induction treatments in ulcerative colitis in comparison with two-item patient-reported outcome.Randomised non-inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild-to-moderate ulcerative colitis.The Management of Inflammatory Bowel Disease in Elderly: Current Evidence and Future PerspectivesConsensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy-Access to Rapid Treatment (iSTART) approach
P2860

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials.

Item
http://www.wikidata.org/entity/Q40520588
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Development of interim patient ...... e activity in clinical trials.
@en
type
label
Development of interim patient ...... e activity in clinical trials.
@en
prefLabel
Development of interim patient ...... e activity in clinical trials.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Development of interim patient ...... e activity in clinical trials.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698